Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol

INTRODUCTION: Insulin standard treatment of T1DM cannot cure the patients as different chronic complications occurred subsequently. Investigations on a curative treatment in T1DM propose cell replacement or maintenance instead of exogenous insulin therapy, but different dimensions of this novel trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Madani, Sedigheh, Larijani, Bagher, Keshtkar, Abbas Ali, Tootee, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787264/
https://www.ncbi.nlm.nih.gov/pubmed/29373983
http://dx.doi.org/10.1186/s13643-017-0662-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787264/
https://www.ncbi.nlm.nih.gov/pubmed/29373983
http://dx.doi.org/10.1186/s13643-017-0662-9

Ejemplares similares